-
need to be developed. We are building a dynamic model based on data from serial liquid biopsies, tissue and imaging. Preliminary evidence suggest that machine learning-powered diagnostic tools based
-
dampen acute clinical symptoms, but do not halt disease progression. Therefore, there remains a great need to better define the underlying processes of MS progression to come to new diagnostic and
-
problems and develop methods for non-English (including Dutch) healthcare data that include (combinations of) free-text clinical notes collected in primary/secondary/intensive care settings, medical images
-
(PET/CT), various MRIs, and include measurements of the amount of tyrosine kinase inhibitors (TKIs) in the blood and in brain tissue from surgery. You will combine these measurements with patient